Status:
COMPLETED
Screening for Gastric Cancer in High-risk Population
Lead Sponsor:
Rabin Medical Center
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-60 years
Brief Summary
Introduction: Gastric cancer is the world's second largest cause of cancer related deaths. In the Western world, as well as in Israel, this malignancy is less prevalent than colorectal cancer, but has...
Detailed Description
High Risk Population First degree relatives of patients with gastric cancer have a 1.5-fold to 3-fold increased risk of developing gastric cancer themselves (Brenner H et al, Cancer 2000;88:274-9). I...
Eligibility Criteria
Inclusion
- First relative, man or woman, of gastric cancer patients.
- Signed informed consent.
- Age 18-60.
Exclusion
- Severe back ground disease.
- State after gastric surgery.
- COPD, CHF, CRF and any disease with respiratory disturbances.
- Deviation of the nasal septum, lack of venous access at the dorsum of the hand or any other technical problem prevents gastric acid collection or base excess evaluation.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00815113
Start Date
October 1 2009
End Date
January 1 2018
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Rabin Medical Center
Petah Tikva, Israel, 49100